Finding the CRISPR off-switch (January 2020)
What legal weed in Canada means for science (October 2018)
A loop of faith (April 2017)
The billion-dollar biotech (June 2015)
To halt brain diseases, drugs take aim at protein traffic jams that kill neurons (January 2019)
Using DNA, radiation therapy gets personal (September 2016)
The new offensive on Alzheimer's disease: Stop it before it starts (February 2017)
Making babies: How to create human embryos with no egg or sperm (April 2018)
Getting on cancer’s nerves: A surprising way to thwart tumours (October 2017)
The appetite genes: Why some of us are born to eat too much (May 2017)
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why (May 2019)
In groundbreaking trials, surgeons to use infected kidneys for transplants (March 2016)
What’s in a biotech name? How drug startups choose their brand (March 2016)
Shoddy biopsies deny cancer patients a shot at personalized treatment (January 2016)
Tomorrow's cancer treatment? (September 2015)
Bioengineers aim to break Big Ag’s addiction to fertilizers (June 2018)
Smart sewers for public health (June 2015)
Bringing HIV labs by backpack to rural Africa (January 2015)
The dappled dilemma facing vitiligo science (April 2019)
How to ruin cancer's day (May 2018)
Stop developing drugs for the cancer that killed my mother (November 2014)
Take two sugar pills and call me in the morning (August 2014)
Moving to Israel may be making Ethiopian Jews sick (August 2015)
A (kosher) can of worms (August 2012)
As testing grows, so do questions about its scope (August 2011)
Israeli curling aims for the big leagues (June 2014)
What’s the Jewish equivalent of a Jamaican bobsledder? Maybe an Israeli curler (February 2014)
Invasion of the hybrids (November 2008)
Hello, Dolly (April 2008)
Mice that eat yogurt have larger testicles (May 2012)
The mathematician versus the malignancy (May 2014)
Call in the backup (November 2012)
Taking tissue engineering to heart (September 2011)
Gene therapy successes point to better therapies (November 2019)
Radiation redux (June 2017)
Combating antibiotic resistance from the ground up (October 2016)
Taking evolution to the clinic (November 2015)
Massive NIH–industry project opens portals to target validation (April 2019)
Cancer immunology community seeks better end points (December 2016)
Oncolytic viruses get a boost with first FDA-approval recommendation (June 2015)
Evolution, resisted (October 2009)
The number two-ome (September 2009)
Now playing: RNA activation (May 2009)
Brain's drain (March 2020)
Cancer–neuronal crosstalk and the startups working to silence it (February 2020)
First eczema biologic debuts but price could restrict use (May 2017)
Early clinical data raise the bar for hemophilia gene therapies (October 2016)
Chromosome instability drives tumor evolution (May 2017)
Top medical centers sign on to single IRB model (April 2017)
iRECIST guideline unveiled for immunotherapies (March 2017)
In good company (December 2017)
A legacy of greater knowledge (August 2017)
Amyotrophic lateral sclerosis: The hexanucleotide hex (October 2017)
Multiple sclerosis: Progressive steps (December 2016)
Schizophrenia: Negative feedback (April 2014)
Could GMO crops help solve the climate crisis? (May 2019)
Canada’s keen on cannabis, but this green rush isn’t so green (December 2018)
A healthy dialogue (June 2015)
A change of heart disease (June 2013)
Tracking down the optimum dose of exercise (July 2015)